An EORTC Gastrointestinal Group phase II evaluation of epirubicin combined with 5-fluorouracil in advanced adenocarcinoma of the pancreas.

Source:http://linkedlifedata.com/resource/pubmed/id/3478197

Download in:

View as

General Info

PMID
3478197